SEAL FOR USE WITH MEDICAL DEVICE AND SYSTEM

Abstract: A seal adapted for use with medical devices is provided. The medical device may be a lead having a distal tip adapted for implantation on or about the heart and for connection to a system for monitoring or stimulating cardiac activity. The lead assembly in one embodiment includes an atraumatic tip. A seal is provided within the lead tip assembly, which prevents or limits further entry of fluids through the lead tip. The lead may be a left ventricular lead with a hemostasis mechanism provided therewithin.

Description: SEAL FOR USE WITH MEDICAL DEVICE AND SYSTEM Field of the Invention The present invention relates generally to medical devices, such as leads and catheters. More particularly, it pertains to seals or hemostasis mechanisms for medical devices such as leads and catheters. Background of the Invention Leads implanted in or about the heart have been used to reverse (i.e., defibrillate or cardiovert) certain life threatening arrhythmias, or to stimulate contraction (pacing) of the heart. Electrical energy is applied to the heart via the leads to return the heart to normal rhythm. Leads have also been used to sense in the atrium or ventricle of the heart and to deliver pacing pulses to the atrium or ventricle. The same lead used to sense the condition is sometimes also used in the process of delivering a corrective pulse or signal from the pulse generator of the pacemaker. Cardiac pacing may be performed by the transvenous method or by leads implanted directly onto the ventricular epicardium. Most commonly, permanent transvenous pacing is performed using a lead positioned within one or more chambers of the heart. A lead, sometimes referred to as a catheter, may be positioned in the right ventricle or in the right atrium through a subclavian vein, and the lead terminal pins are attached to a pacemaker, which is implanted subcutaneously. The lead may also be positioned in both chambers, depending on the lead, as when a lead passes through the atrium to the ventricle. Pacing and sensing electrodes may be positioned within the atrium or the ventricle of the heart. Pacemaker leads represent the electrical link between the pulse generator and the heart tissue, which is to be excited. These pacemaker leads include single or multiconductor coils of insulated wire having an insulating sheath. The coils provide a cylindrical envelope, many times referred to as a lumen, which provides a space into which a stiffening stylet or guidewire can be inserted. The conductive coil is connected to an electrode in an electrode assembly at a distal end of the lead. During use, the lead conducts critical information to and from the heart. The lead, therefore, must remain in sufficient operative condition without interference from entry of bodily fluids. A lumen used as a means for deployment must remain free of blood to remain functional. Clotting blood hampers maneuverability. In addition, blood in the lumen could cause corrosion. To prevent entry of bodily fluids into the lead, a seal can be provided at the distal end of the lead. Conventional leads do not have open ends, i.e. the lumens thereof are closed. Leads which have moving parts, such as retractable fixation parts for example, use O-ring type seals to seal the distal end of the lead from entry of bodily fluids. The O-ring seals can be difficult to manufacture due to dimensional constraints which affect the effectiveness of the seal and the ease with which parts move. Accordingly, there is a need for a lead, which is sufficiently sealed from the environment. There is also a need for a reliable means for performing cardiac sensing and pacing of the left atrium or ventricle, with a lead which is sufficiently sealed from the environment. Summary of the Invention In one embodiment, a body-implantable lead assembly is provided comprising a lead, one end being adapted to be connected to an electrical supply for providing or receiving electrical pulses. The lead further comprises a distal tip, which is adapted to be atraumatic. The lead also has a sheath of material inert to body materials and fluids and at least one conductor extending through the lead body. The lead has a distal electrode adapted for implantation proximate to or within the heart while connected with a system for monitoring or stimulating cardiac activity. The lead, however, is not limited to use in the coronary vascular system. In one embodiment a distal tip electrode is provided which is adapted for implantation proximate to the heart, the electrode being connected with a system for monitoring or stimulating cardiac activity. The lead includes a seal or hemostasis mechanism. The terms "seal", "seal mechanism" and "hemostasis mechanism" may be used interchangeably in describing the present invention. The seal can be in the form of a polymer membrane located at the distal or proximal end of the lead. In one embodiment, the provided medical device includes an electrode tip, supplies a stylet for placement of the lead, which is sealed from exposure to fluids. The lead avoids deterioration of its function due to entry of liquid inside the lead, owing to the provision of a highly effective seal. In addition, the seal remains functional when the lead is removed for short periods of time from an environment filled or partially filled with fluid. The present invention provides a lead, which may be positioned in or on the left ventricle to perform cardiac pacing. In one embodiment the present invention contemplates all types of over the wire leads which have an open distal end, which may be positioned in or on the left chambers of the heart for use in sensing and pacing, and/or "shocking" or cardio verting. The present invention is directed to left ventricular leads providing a hemostasis mechanism or seal in the lead lumen. It has been discovered that a left ventricular lead deployed over a guide wire into the coronary venous system is easily maneuvered into a desired pacing site. It has also been discovered that when the vasculature is unusually difficult or the procedure requires more time, blood can migrate into the lead lumen and begin to coagulate. This can cause undue friction between the lead and the guide wire, interfering with the maneuverability of the lead. Accordingly, the present invention provides an over the wire left ventricular lead having a hemostasis mechanism or seal, which preempts blood from entering the lead lumen. In another embodiment, a hemostasis mechanism for left ventricular leads is provided which comprises a polymer membrane at the proximal or distal end of the lead. The membrane may be a cusp valve made of a suitable biocompatible polymer. In another embodiment, the hemostasis mechanism may be removable and disposable. This embodiment may be removably attached to the terminal pin of the left ventricular lead. In another embodiment, a grommet attachment to the terminal pin in combination with a hemostasis valve which permits the passage of the guide wire and a port for introduction of fluid are provided. The present invention also contemplates the use of the leads and seals disclosed herein as left ventricular leads. These and other embodiments, aspects, advantages, and features of the present invention will be set forth in part in the description which follows, and in part will become apparent to those skilled in the art by reference to the following description of the invention and referenced drawings or by practice of the invention. The aspects, advantages, and features of the invention are realized and attained by means of the instrumentalities, procedures, and combinations particularly pointed out in the appended claims and their equivalents. Brief Description of the Drawings Figure 1 is a side elevational view illustrating a lead constructed in accordance with one embodiment. Figure 2 is a cross-sectional view illustrating a system for delivering signals to the heart constructed in accordance with one embodiment. Figure 3 A is a cross-sectional view of the distal portion of an over the wire left ventricular lead for monitoring and stimulating the heart constructed in accordance with one embodiment. Figure 3B is a cross-sectional view of the proximal portion of an over the wire left ventricular lead for monitoring and stimulating the heart constructed in accordance with one embodiment. Figure 3C is a cross-sectional view of the distal portion of an over the wire left ventricular lead for monitoring and stimulating the heart constructed in accordance with one embodiment. Figure 3D is a cross-sectional view of the distal portion of an over the wire left ventricular lead for monitoring and stimulating the heart constructed in accordance with one embodiment. Figure 4 is an end view of a hemostasis mechanism as shown in Figures 3A-3D, showing an alternative embodiment of a valve. Figure 5 is an end view of a hemostasis mechanism as shown in Figures 3 A-3D, showing an alternative embodiment of a valve. Figure 6 is an end view of a hemostasis mechanism as shown in Figures 3A-3D, showing an alternative embodiment of a valve. Figure 7 is a cross-sectional view of the proximal portion of an over the wire left ventricular lead for monitoring and stimulating the heart constructed in accordance with one embodiment. Figure 8 is a distal end view of a lead seal as shown in Figure 7. Figure 9 is a cross-sectional view of the proximal portion of an over the wire left ventricular lead for monitoring and stimulating the heart constructed in accordance with one embodiment. Description of the Embodiments In the following detailed description, reference is made to the accompanying drawings which form a part hereof, and in which is shown by way of illustration specific embodiments in which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is to be understood that other embodiments may be utilized and that structural changes may be made without departing from the scope of the present invention. Therefore, the following detailed description is not to be taken in a limiting sense, and the scope of the present invention is defined by the appended claims. One embodiment of a lead 10 is illustrated in Figure 1. The lead 10 comprises a lead body 11, and extends from a proximal end 32 to a distal end 30. An elongate conductor is contained within the lead body 11, and a lead tip 20 is disposed within the distal end 30. The lead tip 20 comprises an open lumen lead tip. The stylet 14 stiffens the lead 10, and can be manipulated to introduce an appropriate curvature to the lead 10, facilitating the insertion of the lead 10 into and through a vein and through an intracardiac valve to advance the distal end 30 of the lead 10 into the heart, for example into the right ventricle of the heart. A stylet knob 12 is coupled with the stylet 14 for rotating the stylet 14 and advancing the lead 10. Figure 2 illustrates another embodiment, showing a view of a lead 200 adapted for delivering electrical pulses to stimulate the heart. The lead 200 is not limited to any particular type of lead, but in a preferred embodiment the lead is an open lumen lead, i.e. a lead having a lumen open at its distal end. The lead 200 extends from a proximal end 202, which is adapted to connect with equipment which supplies electrical pulses, to a distal end 204 which is adapted to be inserted into the heart. Proximate to the distal end 204 is an electrode tip 230. The electrode tip 230 includes a seal (Fig. 3A or 3B) disposed therein to preempt bodily fluid from entering through the electrode tip 230. A connector terminal 210 is disposed near the proximal end 202 of the lead 200. The connector terminal 210 electrically connects the various electrodes and conductors within the lead 200 to a pulse sensor and signal generator 240. The pulse sensor and signal generator 240 contains electronics to sense various electrical signals of the heart and also produce electrical pulses for delivery to the heart, depending on the type of lead 200 used. The pulse sensor and signal generator 240 also contains electronics and software necessary to detect certain types of arrhythmias and to correct for them. The lead terminal connector 210 provides for the electrical connection between the lead 200 and the pulse sensor and signal generator 240. Referring to Figures 3 A-3D and 4-6, a hemostasis mechanism for leads, for example left ventricular leads, is shown. The hemostasis mechanism as described herein is used to prevent body fluids from migrating into the lumen of a left ventricular lead during and after deployment into the coronary vascular system. The hemostasis mechanisms described herein apply to sealing the internal lumen of a lead implanted in the heart but are not intended to be limited to that application. The embodiments illustrated in Figures 3 A-3D and 4-6 are directed to over the wire left ventricular leads with hemostasis mechanisms to preempt blood from entering the lead lumen, thus maintaining the superior maneuvering capabilities of the over the wire left ventricular lead. Illustrated in Figure 3A is a lead 300 wherein a hemostasis mechanism 320 is provided. The lead 300 is adapted to be implanted in, on, or around the heart. The lead 300 can comprise a number of configurations such as, although not limited to, those described above and shown in the Figures, for instance the leads shown in Figures 1 and 2. The hemostasis mechanism of the present invention may be utilized with a lead as set forth in U.S. Patent No. 5,155,166, incorporated herein by reference. As shown at Figure 3 A, lead 300 is an over the wire left ventricular lead. Disposed within the lead 300 is a conductor coil 346, which is contained by a lead body 305 having an outer diameter 348. In one embodiment, lead body 305 is made of silicone rubber having an interior layer of polytetrafluoroethylene (PTFE), and conductor coil 346 is made of titanium (Ti). Hemostasis mechanism 320 is located within the lead lumen 344 at or near the distal end 352 of the lead 300. hi an alternative embodiment shown at Figure 3B, hemostasis mechanism 320 is located within the lead lumen 344 at or near the proximal end 354 of the lead 300. Providing a seal at the proximal end puts the point of drag outside the vasculature where it can easily be maneuvered and lubricated as necessary. In a still further embodiment, lead 300 has a first hemostasis mechanism located at or near its distal end 352 (as shown at Figure 3 A), and a second hemostasis mechanism located at or near proximal end 354 (as shown at Figure 3B). In one embodiment, hemostasis mechanism 320 comprises a substantially planar membrane. It should be noted that the hemostasis mechanism 320 optionally has other configurations other than planar. In one embodiment, the membrane is normal to the main axis of the lead 300. In one embodiment, the hemostasis mechanism 320 is comprised of a housing 310 having a polymer membrane 322. Housing 310 is made of any suitable biocompatible material. Housing 310 may be made of molded plastic, or a metal such as titanium. The housing may alternatively be made of silicone rubber or polyurethane, or other biocompatible material. The membrane 322 is made of any suitable biocompatible material. Examples of suitable materials include but are not limited to silicone rubber, polyurethane, hydrogels and other biocompatible elastomers. Membrane 322 is held within housing 310, in one option, by an interference fit. Alternatively, membrane 322 is adhesively bonded to housing 310. As shown in Figures 3C and 3D, housing 310 optionally comprises an annular recessed area 326 in which membrane 322 is held. The hemostasis mechanism 320 is retained within the lead lumen 344 as shown in Figure 3 A. For instance, the housing 310 is a tubular member 312 made of titanium and is laser welded to the lead 300. Alternatively, other attachment methods, such as resistance welding or adhesive bonding, are used. The housing may be attached to the lead proximal to an end of the electrode. Referring to Figure 3D, housing 310 alternatively comprises an indented portion 328 which when inserted in the distal end of the lead 300 defines a proximally facing annular shoulder 330 which meets the exterior of lead 300. In the embodiment shown at Figure 3B, the hemostasis mechanism comprises the terminal pin 355 which serves as a housing in which membrane 322 is held as described herein with regard to housing 310 (Figure 3A). Suitable materials for the terminal pin 355 include, but are not limited to, those described herein with regard to housing 310. In one embodiment, membrane 322 comprises a cusp valve mechanism 324 which allows the passage of a needle 350 or guide wire 350 therethrough and prevents the migration of blood into the lead lumen. In one embodiment, the seal and valve are comprised of silicone rubber or other suitable biocompatible polymer. Variations for the cusp valve mechanism 324 are shown in Figures 4 - 6. Figure 4 shows a quad cusp valve 324 A. In an alternative embodiment, valve 324 is a bicusp valve, as shown at 324B of Figure 5, or a tricusp valve as shown at 324C of Figure 6. In further embodiments the membrane 322 shown at Figure 3A comprises a cusp valve mechanism as shown at Figures 4-6. In further embodiments, the lead shown at Figure 3B comprises a cusp valve mechanism as shown at Figures 4-6. Referring to Figure 7, a seal 720 is shown. The seal comprises a removable disposable mechanism 722 comprising a housing 710 with a membrane 724 housed therein. The housing 710 is attached to the lead body 702 at the proximal end 754 of the lead 700. The housing 710 attaches to the terminal pin 760 of the lead 700. The housing 710 of the seal 720 may be made of molded plastic, silicone rubber, or polyurethane. The membrane 724 is attached to and extends across the interior 726 of the housing 710. In one embodiment, membrane 724 is made of a biocompatible polymeric material, such as silicone rubber or polyurethane. In one embodiment, the membrane is integral with the housing, molded as one piece. The membrane 724 has a small hole or slit 728 (Figure 8) to permit penetration with a needle to fill the lead lumen 744 with saline or other suitable sterile solution. Referring to Figure 8, in one embodiment the membrane has multiple slits 730. When the needle is withdrawn, the polymer membrane 724 closes sufficiently to maintain a hydraulic lock on the fluid in the lumen 744. The guide wire 770, optionally is passed through the membrane 724 and inserted into the lead lumen 744 and the lead 700 is deployed in the usual fashion. In a further option, the lead 700 is deployed using a catheter and/or the guide wire 770. The column of saline, maintained in the lead lumen 744 by the attached membrane 724, an optional second membrane and/or venous pressure, prevents blood from entering the lead lumen 744 and mitigates handling problems due to coagulation of blood within the lead 700. In a method of use, a lead 700 is provided, and a seal 720 is attached to the lead 700, for example, by attaching a housing to the terminal pin 760 of lead body 702 at the proximal end of the lead. A needle is inserted in the hole or slit 728 of the seal membrane 724 to fill the lead lumen 744 with saline or other suitable sterile solution. Venous pressure maintains the column of fluid therein. The needle is withdrawn, and the polymer membrane 724 closes sufficiently to maintain a hydraulic lock on the fluid in the lumen 744. The guide wire 770 is optionally passed through the membrane 724 and inserted into the lead lumen 744. It should be noted that the guide wire 770 can be inserted into the lead lumen 744 prior to or after the filling of the lumen 744 with the sterile solution. The lead 700 is then deployed in the usual fashion. The column of saline is maintained in the lead lumen 744 by the attached membrane 724 and venous pressure and/or an additional distal seal. In one embodiment, lead 700 further comprises a distal hemostasis mechanism, as shown at Figure 3 A, and the column of saline is maintained in the lead lumen 744 between membrane 724 and the membrane of a distal hemostasis mechanism (as shown at 324 of Figure 3 A). The column of saline prevents blood from entering the lead lumen 744 and mitigates handling problems due to coagulation of blood. In an alternative embodiment, the lead is disposed in and guided within a guide catheter before, during, or after the fluid is injected into lumen 744. An alternative embodiment as shown in Figure 9 is a lead 800 having a main lead body portion 802, a lumen 844 and a terminal pin 860. Seal mechanism 820 comprises two grommet style hubs 858 and 862 located at either end of body 830. Seal mechanism 820 is attached to terminal pin 860 by a grommet assembly 858. The grommet assembly 858 is comprised of locking hub 821 and elastomeric grommet 822 and attaches the seal mechanism 820 to lead terminal pin 860 and seals tightly. The hemostasis valve provides for passage of a guide wire (not shown) and is comprised of hub 861 and elastomeric grommet 863. Seal mechanism 820 further comprises a side injection port 880 for periodic or continuous introduction of sterile fluid. It is to be understood that the above description is intended to be illustrative, and not restrictive. Many other embodiments will be apparent to those of skill in the art upon reading and understanding the above description. For instance, the seal can be used with a variety of medical devices. Such a medical device may comprise or require a first seal at its proximal end and a second seal at its distal end. Although the use of the lead has been described for use in a cardiac pacing system, the lead could as well be applied to other types of body stimulating systems. In addition, the lead could also be applicable to bipolar pacing leads having two separate conductors, and to multipolar pacing leads employing multiple conductor leads. The scope of the invention should, therefore, be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled.

Claims: What is claimed is: 1. An intravenous lead comprising: an elongate flexible lead body made of an electrically insulative material, the lead body having a proximal end and a distal end; at least one lumen extending through the lead body from the proximal end toward the distal end, the at least one lumen having a first opening through the proximal end and a second opening through the distal end; a conductive member extending through the lead body from the proximal end toward the distal end of the lead body; at least one electrode electrically coupled to the conductive member; and a hemostasis mechanism comprising a polymer membrane operably coupled with the at least one lumen. 2. The lead as recited in claim 1, wherein the hemostasis mechanism is located near the distal end of the lead. 3. The lead as recited in claim 2, wherein the electrode is located near the distal end of the lead body and the hemostasis mechanism is located distal of the electrode. 4. The lead as recited in claim 1 , wherein the hemostasis mechanism is disposed within the lead lumen. 5. The lead as recited in any of the above recited claims, wherein the hemostasis mechanism is attached to and carried by the lead. 6. The lead as recited in any of the above recited claims, wherein the hemostasis mechanism further comprises a housing in which the polymer membrane is disposed. 7. The lead as recited in claim 6, wherein the housing is tubular. 8. The lead as recited in claim 6, wherein the housing is comprised of silicone rubber or polyurethane or hydrogel. 9. The lead as in claim 8, wherein the housing is adhesively bonded to an interior surface of the lead. 10. The lead as recited in claim 6, wherein the housing is comprised of titanium. 11. The lead as recited in claim 10, wherein the housing is laser welded to the lead proximal to an end of the electrode. 12. The lead as recited in claim 10, wherein the housing is adhesively bonded to the lead proximal to an end of the electrode. 13. The lead as recited in claim 6, wherein the housing further comprises an indentation constructed and arranged to mate with the lead body. 14. The lead as recited in claim 13, wherein the indentation is located at the proximal end of the housing and defines a proximally facing annular shoulder which meets an exterior portion of the distal end of the lead body. 15. The lead as recited in claim 6, wherein the housing comprises an annular recessed area wherein the polymer membrane is held. 16. The lead as recited in claim 6, wherein the polymer membrane is held within the housing by an interference fit. 17. The lead as recited in claim 6, wherein the polymer membrane is adhesively bonded within the housing. 18. The lead as recited in any of the above recited claims, wherein the hemostasis mechanism includes a valve. 19. The lead as recited in claim 18, wherein the valve is comprised of silicone. 20. The lead as recited in claim 19, wherein the valve is a bicusp valve. 21. The lead as recited in claim 19, wherein the valve is a tricusp valve. 22. The lead as recited in claim 19, wherein the valve is a quad cusp valve. 23. The lead as recited in claim 1, wherein the lumen thereof is filled with a sterile fluid, maintained in the lumen by a hydraulic lock provided by the hemostasis membrane. 24. The lead as recited in claim 1, wherein the hemostasis mechanism is removably attached to the lead and is disposable. 25. The lead as recited in claims 1 or 4, wherein the polymer membrane is coupled at the proximal end of the lead body. 26. The lead as recited in claim 1, 4, or 25, wherein the lead body is configured for implantation on or about the left side of the heart, the electrode is located near the distal end of the lead body, and the hemostasis mechanism is located near the proximal end of the lead. 27. The lead as recited in claim 26, wherein the lead is an over-the-wire left ventricular lead having an atraumatic tip. 28. The lead as recited in any of the above recited claims, wherein the polymer membrane is comprised of silicone rubber or polyurethane or a hydrogel. 29. The lead as recited in claims 1, 25, or 26, further comprising a terminal pin, the hemostasis mechanism attached to and extending from the terminal pin. 30. The lead as recited in claims 1, 25, or 26, further comprising a terminal pin, wherein the hemostasis mechanism is integral with and disposed within the terminal pin. 31. The lead as recited in claim 31 , further comprising a port, and wherein the hemostasis mechanism further comprises a grommet, the hemostasis mechanism being removably connected to the terminal pin by the grommet. 32. The lead as recited in claims 1, 25, or 26, wherein the polymer membrane defines at least one hole to allow penetration of the membrane with a needle or a guide wire. 33. The lead as recited in claim 1, 25, or 26, wherein the polymer membrane defines at least one slit adapted to allow penetration of the membrane with a needle or a guide wire. 34. A hemostasis mechanism adapted for use with an implantable intravenous lead, the hemostasis mechanism comprising a tubular housing having a polymer membrane located therein. 35. The hemostasis mechanism of claim 34, wherein the membrane comprises a valve. 36. The hemostasis mechanism of claim 34, wherein the polymer membrane is disposed at the proximal end of the lead body. 37. A method comprising : providing an over-the-wire lead comprising a lead body having a proximal end, a distal end and a terminal pin at the proximal end thereof, the lead body having an interior portion defining a lumen therethrough; positioning a hemostasis mechanism within the lead, the hemostasis mechanism including a polymer membrane; attaching the hemostasis mechanism to the lead by attaching the housing to the terminal pin; and passing a guide wire through the membrane and inserting the guide wire into the lead lumen. 38. The method as recited in claim 37, wherein positioning the hemostasis mechanism includes positioning a hemostasis mechanism comprising a housing with the polymer membrane therein. 39. The method as recited in claim 37, wherein the polymer membrane defines at least one aperture for a needle or guide wire to penetrate the polymer membrane, and inserting a needle in the at least one aperture of the membrane. 40. The method as recited in claim 39, further comprising filling the lead lumen with a sterile fluid, withdrawing the needle from the membrane, where the polymer membrane closes sufficiently to maintain a hydraulic lock on the fluid in the lumen. 41. The method as recited in claim 40, further comprising maintaining the column of saline in the lead lumen with the membrane during deployment of the lead, where the column of sterile fluid prevents non-sterile fluid from entering into the lead lumen. 42. The method as recited in claim 40, further comprising positioning the hemostasis mechanism at the distal end of the lead body. 43. The method as recited in claim 40, further comprising positioning the hemostasis mechanism at the proximal end of the lead body.

Inventors: CREVENSTEN GWEN, LIU LILI, TOCKMAN BRUCE, WESTLUND RANDY, ZERBY CHRISTOPHER M, CREVENSTEN, GWEN, LIU, LILI, TOCKMAN, BRUCE, WESTLUND, RANDY, ZERBY, CHRISTOPHER, M.
Applicants: CARDIAC PACEMAKERS INC, CARDIAC PACEMAKERS, INC.
Application year: 2001
Main classification: A61N1
IPC codes: A61N1